FDA Inspection 1303100 — Putnam Medical Corporation
The FDA completed an inspection of Putnam Medical Corporation on February 10, 2026 in Dayville, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 10, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Dayville, CT (United States)